<DOC>
	<DOC>NCT00934063</DOC>
	<brief_summary>This observational study is conducted in Europe. The aim of this observational study is to investigate the changes in a score (GET-score) which includes quality of life, body composition and cholesterol metabolism in patients on growth hormone treatment. The GET score stands for: Growth hormone deficiency and Efficacy of Treatment, and is a quantitative measurement of the efficacy of the treatment with growth hormone in adults.</brief_summary>
	<brief_title>An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With NorditropinÂ®</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<criteria>Severe acquired growth hormone deficiency No treatment with somatropin in the last 24 months before study participation Written informed consent Contraindications for the treatment with somatropin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>